The potential for POCT in the Internet of Things (IoT)

  • Christina Rode-Schubert
  • Thomas Norgall
  • Andreas Bietenbeck


This chapter deals with current innovative approaches to future developments in POCT and addresses topics such as telemonitoring, ambient assisted living and personalized health (pHealth). Trends in and drivers of personalized health (pHealth) are described with a focus on self-monitoring and the technical basis that engenders these developments. Self-monitoring often relies on wearables: intelligent miniaturized components and/or computer systems integrated in wearable devices. Wearables generally interact wirelessly via networks; broadly speaking, their conceptualization characterizes the Internet of Things (IoT). Methods for analyzing the measurements collected are subsumed under the catchphrase Big Data Analysis.


  1. 1.
    Anonymous (2000) In: Kohn LT, Corrigan JM, Donaldson MS (eds) To err is human: Building a safer health system. Washington (DC)Google Scholar
  2. 2.
    Banaee H, Ahmed MU, Loutfi A (2013) Data mining for wearable sensors in health monitoring systems: a review of recent trends and challenges. Sensors (Basel) 13:17472–17500CrossRefPubMedGoogle Scholar
  3. 3.
    Blenner SR, Köllmer M, Rouse AJ et al. (2016) Privacy policies of android diabetes apps and sharing of health information. JAMA 315:1051–1052CrossRefPubMedGoogle Scholar
  4. 4.
    Freckmann G, Schmid C, Baumstark A et al. (2012) System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol 6:1060–1075CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Gao W, Emaminejad S, Nyein HYY et al. (2016) Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis. Nature 529:509–514CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18. %20Wearable %20Tech %20Report %20Outline.pdf
  19. 19. %E2 %80 %93-die-zukunft- vorhersagen-statt-nur-reports-erstellen
  20. 20.
  21. 21.
  22. 22.
  23. 23.
  24. 24.
  25. 25.
  26. 26.
  27. 27.
  28. 28.
  29. 29.“Wearable Technologies is the pioneer and worldwide leading innovation and market development platform for Technologies worn close to the body, on the body or even in the body”
  30. 30.
  31. 31.
    Kish LJ, Topol EJ (2015) Unpatients – why patients should own their medical data. Nat Biotech 33: 921–924CrossRefPubMedGoogle Scholar
  32. 32.
    Komatireddy R, Topol EJ (2012) Medicine unplugged: the future of laboratory medicine. Clin Chem 58:1644–1647CrossRefPubMedGoogle Scholar
  33. 33.
    Lippi G, Favaloro EJ, Plebani M (2011) Direct-to-consumer testing: more risks than opportunities. Int J Clin Pract 65:1221–1229CrossRefPubMedGoogle Scholar
  34. 34.
    Nichols JH (2011) Blood glucose testing in the hospital: error sources and risk management. J Diabetes Sci Technol 5:173–177CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Schmedt M (2016) Fitness-Tracker: Der Datenhunger wächst. Dtsch Ärztebl International 113: 257–258Google Scholar
  36. 36.
    Swan M (2013) The quantified self: Fundamental disruption in big data science and biological discovery. Big Data 1:85–99CrossRefPubMedGoogle Scholar
  37. 37.
    Varma N (2007) Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Study. Am Heart J;154:1029–1034CrossRefPubMedGoogle Scholar
  38. 38.
    Zeevi D, Korem T, Zmora N et al. (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Christina Rode-Schubert
    • 1
  • Thomas Norgall
    • 2
  • Andreas Bietenbeck
    • 3
  1. 1.TCI GmbHMannheimGermany
  2. 2.Fraunhofer Institut für Integrierte Schaltungen IIS/BMTErlangenGermany
  3. 3.Klinikum rechts der TU MünchenInstitut für Klinische Chemie und PathobiochemieMünchenGermany

Personalised recommendations